Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Farber, MD
University of North Carolina
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Heart Hospital
Phoenix, Arizona, United States
- University of Arizona
Tucson, Arizona, United States
- University of California-San Francisco
San Francisco, California, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- University of Florida
Gainesville, Florida, United States
- Baptist Cardiac and Vascular Institute
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Rockford Memorial Hospital
Rockford, Illinois, United States
- Clarian Cardiovascular
Indianapolis, Indiana, United States
- Indiana Heart Hospial
Indianapolis, Indiana, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- the Mayo Clinic
Rochester, Minnesota, United States
- Albany Medical Center
Albany, New York, United States
- New York Presbyterian Hospital --Columbia/cornell University
New York, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- East Carolina University
Greenville, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Hospital of the University of Pennsylvania/penn Presbyterian
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Methodist Hospital
Houston, Texas, United States
- Inova Fairfax Hospital
Falls Church, Virginia, United States
- Sentara Heart Hospital
Norfolk, Virginia, United States
- University of Washington
Seattle, Washington, United States
- Aurora St. Luke'S Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2007
- Primary completion
- 30 Apr 2011
- Completion
- 15 May 2017
- Last update posted
- 16 Jan 2018
- Registered enrollment
- 180
- Registry id
- NCT00435942
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.